News Posts List
New robotic kidney tumor procedure benefits high-risk patients
12/28/2013
Surgeons at Beaumont Health System are pioneering a technique that uses robotic surgery to remove cancerous kidney tumors in patients with only one kidney.
Kidney Cancer Association Live Support Online through New Year’s Day
12/27/2013
Global cancer charity strives to serve patients through the holiday.
Kidney Cancer Association Live Support Online Christmas Day
12/24/2013
World’s Largest Renal Cancer Charity Strives to Serve Patients Through the Holiday
Sunlight exposure may cause skin tumour development in TSC
12/23/2013
UV rays in sunlight cause DNA damage and sun exposure is a major risk factor in most skin cancers. A recent study from Harvard suggests that sun exposure may also worsen the number and severity of skin lesions found in tuberous sclerosis patients (Tyburczy et al., 2013)
Cancer Research UK and AstraZeneca sign deal to repurpose asthma drug that could fight kidney cancer
12/23/2013
Cancer Research UK and Cancer Research Technology – the charity’s development and commercialisation arm – have reached an agreement with AstraZeneca to take AZD2098, an experimental drug originally designed for asthma, into a clinical trial to treat kidney cancer.
NEWLINK GENETICS LAUNCHES PHASE I CLINICAL TRIAL
12/20/2013
NewLink Genetics Corporation (NASDAQ: NLNK), a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced that it had launched a first in human Phase 1 clinical trial of HyperAcute Renal immunotherapy in patients with metastatic renal cell cancer.
Cancer Immunotherapy Named Science 'Breakthrough of the Year'
12/20/2013
A type of cancer treatment that directs the body's own immune system to fight cancer cells has been named as the "breakthrough of the year" by one of the world's top science journals.
Merck, Glaxo to Partner on Renal Cell Cancer Treatment
12/19/2013
Merck is looking for more collaborations like the one with Glaxo to test how MK-3475 works with other anticancer treatments against a variety of tumor types...
Technology shortens cancer treatment time
12/18/2013
"I had very minor side effects," Bachelor said. "After the last one, I just had a little tiredness for a few days."
STK15 F31I Polymorphism and Cancer Susceptibility
12/17/2013
The association between the Serine/threonine kinase 15 (STK15) F31I polymorphism (rs2273535) and cancer susceptibility remains controversial. To further investigate this potential relationship, we conducted a comprehensive meta-analysis of 27 published studies involving a total of 19,267 multiple cancer cases and 24,359 controls.
News Feed